A high-quality consumer franchise with a perfect four-quarter earnings-beat streak and free cash flow that exceeds net income has run above its near-term price target, leaving a marginally unfavorable risk/reward with downside slightly exceeding residual upside; the investment case rests on the quality and consistency of the business, but the current price offers little entry cushion.
Thesis pillars
- Consistent Earnings Delivery→Stable
- Price Above Near Term Target↓Deteriorating
- Elevated Leverage Limits Flexibility↓Deteriorating
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 23, 2026· older than 90 days
Colgate-Palmolive Company (CL) Stock Analysis
Breakout setup
Consumer Defensive · Household & Personal Products
Sell if holding. Analyst target reached at $98.76 — A.R:R is negative (-0.6) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (0.9% away).
Colgate-Palmolive markets oral, personal, home care, and pet nutrition products across 200+ countries, with Oral Care (Colgate, elmex, Tom's of Maine) at 44% and Pet Nutrition (Hill's) at 23% of 2025 net sales. Walmart represented approximately 11% of net sales in 2025, the only... Read more
Sell if holding. Analyst target reached at $98.76 — A.R:R is negative (-0.6) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (0.9% away). Chart setup: Golden cross, above all MAs, RSI 63, MACD bullish. Score 5.2/10, moderate confidence.
Passes 5/7 gates (positive momentum, clean insider activity, earnings proximity 85d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and 8k serious 2.05. Suitability: conservative.
Recent developments
updated Nov 4, 2026Recent Developments — Colgate-Palmolive Company
Latest news
- NEWS U.S. Environmental Protection Agency Reaches Settlement With Colgate-Palmolive To Bring It Into Compliance With Requirem — benzinga Nov 4, 2026 negative
- NEWS Colgate-Palmolive Slips as Investors Reassess Defensive Rally Ahead of Earnings - Moomoo — Moomoo Oct 29, 2026 negative
- NEWS Why Is Colgate-Palmolive (NYSE:CL) Drawing Attention Ahead of Its Earnings Call? - Kalkine Media — Kalkine Media Oct 29, 2026 neutral
- NEWS Colgate-Palmolive (CL) Stock May Be 28% Undervalued On Cash Flow - Yahoo Finance — Yahoo Finance Oct 28, 2026 positive
- NEWS Crude Oil Prices Surge Amid Middle East Tensions; Colgate-Palmolive (CL) Dividend Stability in Focus - GuruFocus — GuruFocus Oct 28, 2026 neutral
Latest item Nov 4, 2026 · Generated 2026-11-05T11:49:09Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- LOWCustomerWalmart11%10-K Item 1: 'Our sales to Walmart, Inc. and its affiliates represented approximately 11% of our Net sales in 2025.'
- MEDIUMProductOral Care44%10-K Item 1: 'Sales of Oral, Personal and Home Care products accounted for 44%, 17% and 16%, respectively, of our total worldwide Net sales in 2025.'
- MEDIUMSuppliersingle-source suppliers10-K Item 1: 'We do, however, purchase certain key raw and packaging materials from single-source suppliers or a limited number of suppliers'
Material Events(8-K, last 90d)
- 2026-05-01Item 2.05MEDIUMUpdate on Strategic Growth and Productivity Program (Board-approved July 31, 2025): three-year initiative to realign organizational structure in support of 2030 strategy. Filing discloses costs associated with exit or disposal activities; specific charge amount truncated in available excerpt.SEC filing →
- 2026-04-09Item 5.02MEDIUMJennifer M. Daniels (CLO and Secretary since 2014) announced retirement in 2026. Betsy Fishbone (EVP and Deputy CLO) elected CLO and Secretary effective June 1, 2026; Daniels transitions to Vice Chair for orderly handoff.SEC filing →
- 2026-03-12Item 5.02LOWChristopher S. Boerner, Ph.D. (CEO and Board Chair of Bristol-Myers Squibb) elected to Colgate-Palmolive Board, effective March 15, 2026. Board appointment only; no officer change.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $98.76 — A.R:R is negative (-0.6) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (0.9% away). Chart setup: Golden cross, above all MAs, RSI 63, MACD bullish. Prior stop was $93.94. Score 5.2/10, moderate confidence.
Analyst target $91.53 reached (−7.3% from $98.76); no take-profit level is published. Prior stop was $93.94. Stop-loss: $93.94.
Analyst target reached - limited upside remaining; Near 52-week high (0.9% away); Leverage penalty (D/E 12.1): -1.5.
Colgate-Palmolive Company trades at a P/E of 38.4 (forward 24.1). TrendMatrix value score: 4.5/10. Verdict: Sell.
30 analysts rate CL, with a consensus score of 3.8/5. 20 analysts publish price targets averaging $102.
What does Colgate-Palmolive Company do?Colgate-Palmolive markets oral, personal, home care, and pet nutrition products across 200+ countries, with Oral Care...
Colgate-Palmolive markets oral, personal, home care, and pet nutrition products across 200+ countries, with Oral Care (Colgate, elmex, Tom's of Maine) at 44% and Pet Nutrition (Hill's) at 23% of 2025 net sales. Walmart represented approximately 11% of net sales in 2025, the only disclosed customer above 10%; two-thirds of revenues originate outside the United States. The company employs approximately 33,600 people across more than 100 countries.